BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 26837447)

  • 21. Gastric amyloidosis: clinicopathological correlations in 79 cases from a single institution.
    Said SM; Grogg KL; Smyrk TC
    Hum Pathol; 2015 Apr; 46(4):491-8. PubMed ID: 25649008
    [TBL] [Abstract][Full Text] [Related]  

  • 22. How I treat amyloidosis: the importance of accurate diagnosis and amyloid typing.
    Leung N; Nasr SH; Sethi S
    Blood; 2012 Oct; 120(16):3206-13. PubMed ID: 22948045
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Imaging mass spectrometry analysis of renal amyloidosis biopsies reveals protein co-localization with amyloid deposits.
    Casadonte R; Kriegsmann M; Deininger SO; Amann K; Paape R; Belau E; Suckau D; Fuchser J; Beckmann J; Becker M; Kriegsmann J
    Anal Bioanal Chem; 2015 Jul; 407(18):5323-31. PubMed ID: 25935672
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amyloidosis: a clinical overview.
    Hazenberg BP
    Rheum Dis Clin North Am; 2013 May; 39(2):323-45. PubMed ID: 23597967
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Laser microdissection and mass spectrometry-based proteomics aids the diagnosis and typing of renal amyloidosis.
    Sethi S; Vrana JA; Theis JD; Leung N; Sethi A; Nasr SH; Fervenza FC; Cornell LD; Fidler ME; Dogan A
    Kidney Int; 2012 Jul; 82(2):226-34. PubMed ID: 22495291
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [New trends in the treatment of amyloidosis].
    Martínez-Valle F; Gironella-Mesa M; Solans-Laqué R
    Med Clin (Barc); 2012 May; 138(15):667-72. PubMed ID: 22197598
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Medullary amyloidosis associated with apolipoprotein A-IV deposition.
    Sethi S; Theis JD; Shiller SM; Nast CC; Harrison D; Rennke HG; Vrana JA; Dogan A
    Kidney Int; 2012 Jan; 81(2):201-6. PubMed ID: 21900878
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amyloidosis and Amyloidogenesis: One Name, Many Diseases.
    Pozzan M; Indennidate C; Varrà GG; Sinagra G; Merlo M; Pagura L
    Heart Fail Clin; 2024 Jul; 20(3):249-260. PubMed ID: 38844296
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathogenesis, diagnosis and treatment of systemic amyloidosis.
    Pepys MB
    Philos Trans R Soc Lond B Biol Sci; 2001 Feb; 356(1406):203-10; discussion 210-1. PubMed ID: 11260801
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hereditary systemic amyloidosis with renal involvement.
    Hawkins PN
    J Nephrol; 2003; 16(3):443-8. PubMed ID: 12832750
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Classification of amyloidosis].
    Misumi Y; Ando Y
    Brain Nerve; 2014 Jul; 66(7):731-7. PubMed ID: 24998818
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Renal amyloidosis associated with a novel sequence variant of gelsolin.
    Sethi S; Theis JD; Quint P; Maierhofer W; Kurtin PJ; Dogan A; Highsmith EW
    Am J Kidney Dis; 2013 Jan; 61(1):161-6. PubMed ID: 22938848
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amyloid nephropathy.
    Khalighi MA; Dean Wallace W; Palma-Diaz MF
    Clin Kidney J; 2014 Apr; 7(2):97-106. PubMed ID: 25852856
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Systemic amyloidoses in renal biopsy samples].
    Bauerová L; Honsová E; Rysavá R; Povýsil C
    Cesk Patol; 2009 Jul; 45(3):64-8. PubMed ID: 19764159
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Twists and turns of determining amyloid type and amyloid-related organ damage: discordance and clinical skepticism in the era of proteomic typing.
    Kaul E; Pilichowska M; Vullaganti M; Madan N; Comenzo RL
    Amyloid; 2014 Mar; 21(1):62-5. PubMed ID: 24256111
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hyphenated Mass Spectrometry Techniques in the Diagnosis of Amyloidosis.
    Spodzieja M; Rodziewicz-Motowidło S; Szymanska A
    Curr Med Chem; 2019; 26(1):104-120. PubMed ID: 28971756
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exploring the amyloid proteome in immunoglobulin-derived lymph node amyloidosis using laser microdissection/tandem mass spectrometry.
    D'Souza A; Theis J; Quint P; Kyle R; Gertz M; Zeldenrust S; Vrana J; Dogan A; Dispenzieri A
    Am J Hematol; 2013 Jul; 88(7):577-80. PubMed ID: 23606017
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Fibril-forming proteins: the amyloidosis. New hopes for a disease that cardiologists must know].
    Arbustini E; Gavazzi A; Merlini G
    Ital Heart J Suppl; 2002 Jun; 3(6):590-7. PubMed ID: 12116807
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Histopathological diagnosis of amyloidosis].
    Hoshii Y
    Rinsho Byori; 2006 May; 54(5):513-8. PubMed ID: 16789423
    [TBL] [Abstract][Full Text] [Related]  

  • 40. No regression of renal amyloid mass despite remission of nephrotic syndrome in a patient with TRAPS following etanercept therapy.
    Simsek I; Kaya A; Erdem H; Pay S; Yenicesu M; Dinc A
    J Nephrol; 2010; 23(1):119-23. PubMed ID: 20091495
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.